ABCC3 and breast cancer: Kaplan-Meier analysis revealed that breast cancer patients with high MRP3 expression have shorter overall survival (OS) and progression-free survival (PFS) compared to those with low MRP3 expression, a difference that is statistically significant (P < 0.05).